Metabolic effects of Anti-Müllerian hormone (AMH) and Myonectin in Polycystic ovary syndrome Iraqi women
DOI:
https://doi.org/10.48047/ceb4kw90Keywords:
Polycystic ovary syndrome; Body Mass Index; Anti-Müllerian hormone; MyonectinAbstract
Background and aim: poly cystic ovarian syndrome is a common reproductive dysfunction associated with metabolic dysregulation. This study aims to investigate the metabolic effects of Anti-Müllerian Hormone (AMH) and Myonectin in Iraqi women with PCOS.
Downloads
References
Neven, A.C., et al., Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis. European Journal of Endocrinology, 2024. 191(4): p. S15- S27. 2. Azziz, R., Polycystic ovary syndrome. Obstetrics & Gynecology, 2018. 132(2): p. 321-336.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.